Literature DB >> 20601087

Regulation of the p53 pathway by ubiquitin and related proteins.

Andreas Hock1, Karen H Vousden.   

Abstract

The p53 tumour suppressor protein is subject to many levels of control, including modification with ubiquitin and related proteins such as SUMO and NEDD8. These modifications regulate p53 at a number of levels, including control of protein turnover, alterations in sub-cellular localization and changes in the ability to regulate gene expression. Numerous E3 ligases that can mediate these modifications of p53 have been described, some of which promote conjugation with more than one ubiquitin-like protein. Understanding the complexity of this mechanism of p53 regulation will help in the development of therapeutic drugs that function to modulate these events. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20601087     DOI: 10.1016/j.biocel.2010.06.011

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  33 in total

1.  Extensive post-translational modification of active and inactivated forms of endogenous p53.

Authors:  Caroline J DeHart; Jasdave S Chahal; S J Flint; David H Perlman
Journal:  Mol Cell Proteomics       Date:  2013-09-20       Impact factor: 5.911

Review 2.  Post-translational modification and protein sorting to small extracellular vesicles including exosomes by ubiquitin and UBLs.

Authors:  Hiroshi Ageta; Kunihiro Tsuchida
Journal:  Cell Mol Life Sci       Date:  2019-07-30       Impact factor: 9.261

Review 3.  Towards an understanding of the role of p53 in adrenocortical carcinogenesis.

Authors:  Jonathan D Wasserman; Gerard P Zambetti; David Malkin
Journal:  Mol Cell Endocrinol       Date:  2011-09-10       Impact factor: 4.102

4.  E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.

Authors:  Christopher T Coey; Megan E Fitzgerald; Atanu Maiti; Katherine H Reiter; Catherine M Guzzo; Michael J Matunis; Alexander C Drohat
Journal:  J Biol Chem       Date:  2014-04-21       Impact factor: 5.157

5.  E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis.

Authors:  Ju Liu; C Zhang; X L Wang; P Ly; V Belyi; Z Y Xu-Monette; K H Young; W Hu; Z Feng
Journal:  Cell Death Differ       Date:  2014-08-22       Impact factor: 15.828

6.  The RAX/PACT-PKR stress response pathway promotes p53 sumoylation and activation, leading to G₁ arrest.

Authors:  Richard L Bennett; Yu Pan; Jaime Christian; Teng Hui; W Stratford May
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

7.  Supervillin-mediated suppression of p53 protein enhances cell survival.

Authors:  Zhiyou Fang; Elizabeth J Luna
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

Review 8.  The nucleolus under stress.

Authors:  Séverine Boulon; Belinda J Westman; Saskia Hutten; François-Michel Boisvert; Angus I Lamond
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

Review 9.  Drugging the p53 pathway: understanding the route to clinical efficacy.

Authors:  Kian Hoe Khoo; Khoo Kian Hoe; Chandra S Verma; David P Lane
Journal:  Nat Rev Drug Discov       Date:  2014-03       Impact factor: 84.694

10.  Up-regulation of Smurf1 after spinal cord injury in adult rats.

Authors:  Debao Li; Jinlong Zhang; Wei Huang; Huricha Jin; Aiguo Shen; Longfei Yang; Jian Liu; Jianbo Fan; Qingzhong Zhou; Hai Wen; Yong Hu; Zhiming Cui
Journal:  J Mol Histol       Date:  2013-04-18       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.